Latest Articles

In this instalment of The Evolution of Proteomics, we speak with Dr Alexander Makarov, Director of Research in Life Sciences Mass Spectrometry (MS) at Thermo Scientific, and world-renowned inventor of the Orbitrap mass analyzer technology.

In partnership with researchers from Raytheon and other universities, Eric Young, assistant professor of chemical engineering at Worcester Polytechnic Institute, is creating a method for using DNA signatures to identify genetically engineered organisms in the wild. We spoke with Young to learn more about why such tools are needed and the process of their development.

The development of technical grade pesticides has enabled farmers to reduce crop losses, but it is important to recognize that pesticides are toxic by design, and so it is also important to have sufficient technology to monitor their presence in our produce and on our farmland. We take a look at some alternative techniques that are being applied to this issue.

Structural biology has recently observed the marrying of two remarkably complimentary techniques for the study of protein structure and interaction: cross-linking mass spectrometry (XL-MS) and the Nobel prize winning cryogenic electron microscopy (cryo-EM).

In this instalment of The Evolution of Proteomics, Gary Kruppa, Vice President of Proteomics, Bruker Daltonics Inc., discusses the recent technological advances that are driving MS-based plasma proteomics for biomarker discovery and beyond.

The British Neuroscience Association's Festival of Neuroscience 2019 put improving research practice and methods at the forefront. In this article, the University of Bath's Naomi Heffer takes a look over why the BNA is promoting research "credibility", and what it means for the neuroscience community.

Richard Scheltema is an assistant professor at Utrecht University where he heads up the Scheltema laboratory within the wider context of the group of Albert Heck. The research group focuses on mass spectrometry (MS) based structural proteomics, for which they develop advanced liquid chromatography-mass spectrometry (LC-MS/MS) platforms and analysis software.

In this interview, award-winning scientist Jennifer A. Doudna PhD – renowned for her fundamental work and leadership in developing CRISPR-mediated genome editing – touches on her current research focus, her greatest professional achievements and discusses what can be done to encourage more women to get involved in science.

The question perhaps is not when native mass spectrometry can be used; but rather, when can’t it be used? Today, the applications are broad-reaching and diverse. This article shares insights from innovators in the field who have helped establish this incredibly useful analytical technique.

The "molecular age" of cancer research is here, thanks to advances in next generation sequencing (NGS) which have catalyzed progress in countless areas of cancer research. Find out about the latest studies where NGS is improving our ability to detect cancer, match the best drugs to patients, and monitor treatment success.